Residual Tricuspid Regurgitation After Tricuspid Transcatheter Edge-to-Edge Repair: Insights Into the EuroTR Registry
European Journal of Heart Failure · 01.08.2024 · 26 (8) · 1850-1860
DOI: 10.1002/ejhf.3274 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Heart Failure, online erschienen am 29.05.2024. Verfasst von Lukas Stolz und 46 weiteren Autor:innen. Beteiligte Einrichtung: Medizinische Klinik und Poliklinik I, LMU Klinikum, LMU München, Munich, Germany. Hauptthemen laut MEDLINE: Tricuspid Valve Insufficiency, Registries, Cardiac Catheterization. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aims
Data on the prognostic impact of residual tricuspid regurgitation (TR) after tricuspid transcatheter edge-to-edge repair (T-TEER) are scarce. The aim of this analysis was to evaluate 2-year survival and symptomatic outcomes of patients in relation to residual TR after T-TEER. Methods and results Using the large European Registry of Transcatheter Repair for Tricuspid Regurgitation (EuroTR registry) we investigated the impact of residual TR on 2-year all-cause mortality and New York Heart Association (NYHA) functional class at follow-up. The study further identified predictors for residual TR ≥3+ using a logistic regression model. The study included a total of 1286 T-TEER patients (mean age 78.0 ± 8.9 years, 53.6% female). TR was successfully reduced to ≤1+ in 42.4%, 2+ in 40.0% and 3+ in 14.9% of patients at discharge, while 2.8% remained with TR ≥4+ after the procedure. Residual TR ≥3+ was an independent multivariable predictor of 2-year all-cause mortality (hazard ratio 2.06, 95% confidence interval 1.30–3.26, p = 0.002). The prevalence of residual TR ≥3+ was four times higher in patients with higher baseline TR (vena contracta >11.1 mm) and more severe tricuspid valve tenting (tenting area >1.92 cm2). Of note, no survival difference was observed in patients with residual TR ≤1+ versus 2+ (76.2% vs. 73.1%, p = 0.461). The rate of NYHA functional class ≥III at follow-up was significantly higher in patients with residual TR ≥3+ (52.4% vs. 40.5%, p < 0.001). Of note, the degree of TR reduction significantly correlated with the extent of symptomatic improvement (p = 0.012).
Conclusions
T-TEER effectively reduced TR severity in the majority of patients. While residual TR ≥3+ was associated with worse outcomes, no differences were observed for residual TR 1+ versus 2+. Symptomatic improvement correlated with the degree of TR reduction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medizinische Klinik und Poliklinik I, LMU Klinikum, LMU München, Munich, Germany.
- Department of Cardiology, Cardiology I, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
- Department of Cardiology, Heart Center, University of Cologne, Cologne, Germany.
- Department of General and Interventional Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany.
- Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- German Center of Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Germany.
Zitieren
APA
Stolz, L., Kresoja, K. P., von Stein, J., Fortmeier, V., Koell, B., Rottbauer, W., Kassar, M., Goebel, B., Denti, P., Achouh, P., Rassaf, T., Barreiro-Perez, M., Boekstegers, P., Rück, A., Doldi, P. M., Novotny, J., Zdanyte, M., Adamo, M., Vincent, F., …, & on behalf of the EuroTR Investigators (2024). Residual Tricuspid Regurgitation After Tricuspid Transcatheter Edge-to-Edge Repair: Insights Into the EuroTR Registry. European Journal of Heart Failure, 26(8), 1850-1860. https://doi.org/10.1002/ejhf.3274
Vancouver
Stolz L, Kresoja KP, von Stein J, Fortmeier V, Koell B, Rottbauer W, et al. Residual Tricuspid Regurgitation After Tricuspid Transcatheter Edge-to-Edge Repair: Insights Into the EuroTR Registry. European Journal of Heart Failure. 2024;26(8):1850-1860. doi:10.1002/ejhf.3274
BibTeX
@article{Stolz2024,
author = {Stolz, Lukas and Kresoja, Karl-Patrik and von Stein, Jennifer and Fortmeier, Vera and Koell, Benedikt and Rottbauer, Wolfgang and Kassar, Mohammad and Goebel, Bjoern and Denti, Paolo and Achouh, Paul and Rassaf, Tienush and Barreiro-Perez, Manuel and Boekstegers, Peter and Rück, Andreas and Doldi, Philipp M and Novotny, Julia and Zdanyte, Monika and Adamo, Marianna and Vincent, Flavien and Schlegel, Philipp and von Bardeleben, Ralph-Stephan and Stocker, Thomas J and Weckbach, Ludwig T and Wild, Mirjam G and Brunner, Stephanie and Toggweiler, Stefan and Grapsa, Julia and Patterson, Tiffany and Thiele, Holger and Kister, Tobias and Konstandin, Mathias H and Van Belle, Eric and Metra, Marco and Geisler, Tobias and Estévez-Loureiro, Rodrigo and Luedike, Peter and Karam, Nicole and Maisano, Francesco and Lauten, Philipp and Praz, Fabien and Kessler, Mirjam and Kalbacher, Daniel and Rudolph, Volker and Iliadis, Christos and Lurz, Philipp and Hausleiter, Jörg and on behalf of the EuroTR Investigators, on behalf of the EuroTR Investigators},
title = {Residual Tricuspid Regurgitation After Tricuspid Transcatheter Edge-to-Edge Repair: Insights Into the EuroTR Registry},
journal = {European Journal of Heart Failure},
year = {2024},
volume = {26},
number = {8},
pages = {1850--1860},
doi = {10.1002/ejhf.3274}
}
EUVIMED